Ciutat Sanitària i Universitaria de la Vall d'Hebron

Barcelona 08035

0 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic Solid Tumor, Carcinoma, Transitional Cell, Medical Oncology, Neoplasms, Ovarian Neoplasms, Thrombosis

Studies at this site

• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed
• Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed
• Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole — Completed
• Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer — Completed
• Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children — Completed